These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 2260622
1. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. Diamond JR, Anderson S. Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622 [Abstract] [Full Text] [Related]
2. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM. J Clin Invest; 1988 Nov; 82(5):1757-68. PubMed ID: 2846658 [Abstract] [Full Text] [Related]
3. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Eddy AA, McCulloch L, Liu E, Adams J. Am J Pathol; 1991 May; 138(5):1111-23. PubMed ID: 2024704 [Abstract] [Full Text] [Related]
4. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Ebihara I, Nakamura T, Tomino Y, Koide H. Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058 [Abstract] [Full Text] [Related]
5. Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy. Marinides GN, Groggel GC, Cohen AH, Cook T, Baranowski RL, Westenfelder C, Border WA. Am J Pathol; 1987 Nov; 129(2):394-401. PubMed ID: 2823616 [Abstract] [Full Text] [Related]
6. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis. Herman-Edelstein M, Chagnac A, Nevo Z, Skutelsky E, Evron Y, Hirsch Y, Ben-Dor L, Schwartz I, Schwartz D, Weinstein T. Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087 [Abstract] [Full Text] [Related]
7. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis. Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y. J Nephrol; 2002 Nov; 15(1):36-41. PubMed ID: 11936424 [Abstract] [Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U. Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951 [Abstract] [Full Text] [Related]
9. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy. Trachtman H, Del Pizzo R, Valderrama E, Gauthier B. Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316 [Abstract] [Full Text] [Related]
10. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant. Magil A. J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623 [Abstract] [Full Text] [Related]
11. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome]. Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M. Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472 [Abstract] [Full Text] [Related]
12. Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model. Hamar P, Kerjaschki D. Am J Physiol Heart Circ Physiol; 2016 Oct 01; 311(4):H981-H990. PubMed ID: 27496878 [Abstract] [Full Text] [Related]
13. [Relativity of nuclear factor-kappaB (P65/Rel-A) and angiotensin II type 1 receptor expression in early stage of lesions of adriamycin nephrosis in young rats and the effects of intervention]. Ma H, Li Z, Meng QH, Li XH, Wang XH, Li H, Li WW. Zhonghua Er Ke Za Zhi; 2004 Apr 01; 42(4):275-9. PubMed ID: 15157388 [Abstract] [Full Text] [Related]
14. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats. Radin MJ, Wilke WL, Fettman MJ. Res Commun Chem Pathol Pharmacol; 1986 Nov 01; 54(2):279-82. PubMed ID: 3538253 [Abstract] [Full Text] [Related]
15. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. J Urol; 2001 Jul 01; 166(1):275-80. PubMed ID: 11435885 [Abstract] [Full Text] [Related]
16. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Grond J, Weening JJ, Elema JD. Lab Invest; 1984 Sep 01; 51(3):277-85. PubMed ID: 6471809 [Abstract] [Full Text] [Related]
17. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Wang H, Li J, Yu L, Zhao Y, Ding W. Life Sci; 2004 Feb 13; 74(13):1645-58. PubMed ID: 14738908 [Abstract] [Full Text] [Related]
18. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A. Kidney Int; 1994 Feb 13; 45(2):537-43. PubMed ID: 8164442 [Abstract] [Full Text] [Related]
19. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Nomura A, Morita Y, Maruyama S, Hotta N, Nadai M, Wang L, Hasegawa T, Matsuo S. Am J Pathol; 1997 Aug 13; 151(2):539-47. PubMed ID: 9250166 [Abstract] [Full Text] [Related]